Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy

Detalles Bibliográficos
Autores principales: Ritter, Violetta, Krautter, Franziska, Klein, Diana, Jendrossek, Verena, Rudner, Justine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018877/
https://www.ncbi.nlm.nih.gov/pubmed/35440079
http://dx.doi.org/10.1038/s41419-022-04743-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018877/
https://www.ncbi.nlm.nih.gov/pubmed/35440079
http://dx.doi.org/10.1038/s41419-022-04743-7

Ejemplares similares